130 related articles for article (PubMed ID: 1377163)
1. CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity.
Wong KF; Chan JK; Ng CS; Lee KC; Tsang WY; Cheung MM
Hum Pathol; 1992 Jul; 23(7):798-804. PubMed ID: 1377163
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract.
Nakamura S; Suchi T; Koshikawa T; Kitoh K; Koike K; Komatsu H; Iida S; Kagami Y; Ogura M; Katoh E
Am J Surg Pathol; 1995 Mar; 19(3):284-96. PubMed ID: 7532919
[TBL] [Abstract][Full Text] [Related]
3. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas.
Tsang WY; Chan JK; Yip TT; Ng CS; Wong KF; Poon YF; Ma VW
Hum Pathol; 1994 Aug; 25(8):758-65. PubMed ID: 7520016
[TBL] [Abstract][Full Text] [Related]
4. CD56 (NCAM)-positive malignant lymphoma.
Wong KF; Chan JK; Ng CS
Leuk Lymphoma; 1994 Jun; 14(1-2):29-36. PubMed ID: 7522719
[TBL] [Abstract][Full Text] [Related]
5. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
Nichols GE; Normansell DE; Williams ME
Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
[TBL] [Abstract][Full Text] [Related]
6. NCAM (CD56)-positive malignant lymphoma.
Kern WF; Spier CM; Miller TP; Grogan TM
Leuk Lymphoma; 1993 Dec; 12(1-2):1-10. PubMed ID: 7512851
[TBL] [Abstract][Full Text] [Related]
7. Challenge in diagnosis of CD56+ lymphoproliferative disorders: two cases of CD56+CD33+ lymphoma/leukemia.
Yang X; Wasserman PG; Bhargava A; Iqbal U; Ragnauth S; Fuchs A
Arch Pathol Lab Med; 2004 Aug; 128(8):e100-3. PubMed ID: 15270596
[TBL] [Abstract][Full Text] [Related]
8. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement.
Kato N; Yasukawa K; Onozuka T; Kikuta H
J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634
[TBL] [Abstract][Full Text] [Related]
9. CD56-positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease.
Savoia P; Fierro MT; Novelli M; Quaglino P; Verrone A; Geuna M; Bernengo MG
Br J Dermatol; 1997 Dec; 137(6):966-71. PubMed ID: 9470917
[TBL] [Abstract][Full Text] [Related]
10. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
11. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma.
Adachi M; Maeda K; Takekawa M; Hinoda Y; Imai K; Sugiyama S; Yachi A
Am J Hematol; 1994 Dec; 47(4):278-82. PubMed ID: 7526680
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biologic features of CD4(+)CD56(+) malignancies.
Feuillard J; Jacob MC; Valensi F; Maynadié M; Gressin R; Chaperot L; Arnoulet C; Brignole-Baudouin F; Drénou B; Duchayne E; Falkenrodt A; Garand R; Homolle E; Husson B; Kuhlein E; Le Calvez G; Sainty D; Sotto MF; Trimoreau F; Béné MC
Blood; 2002 Mar; 99(5):1556-63. PubMed ID: 11861268
[TBL] [Abstract][Full Text] [Related]
13. Agranular CD4+/CD56+ cutaneous neoplasm.
Touahri T; Belaouni H; Mossafa H; Pulik M; Bourguigna L; Ibbora C; Dal Soglio D; Davi F; Fourcade C
Leuk Lymphoma; 2002 Jul; 43(7):1475-9. PubMed ID: 12389632
[TBL] [Abstract][Full Text] [Related]
14. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic analysis of benign and malignant cutaneous lymphoid infiltrates.
Rest EB; Horn TD
Clin Dermatol; 1991; 9(2):261-72. PubMed ID: 1660786
[No Abstract] [Full Text] [Related]
16. Cases of cutaneous and nasal CD56 (NCAM)-positive lymphoma in Japan have differences in immunohistology, genotype, and etiology.
Takeshita M; Yoshida K; Suzumiya J; Kikuchi M; Kimura N; Uike N; Okamura T; Nakayama J; Komiyama S
Hum Pathol; 1999 Sep; 30(9):1024-34. PubMed ID: 10492036
[TBL] [Abstract][Full Text] [Related]
17. Intracytoplasmic localization of CD3 antigen in NKH1+ azurophilic granular T-lymphoblastic lymphoma cells.
Yoda Y; Mori N; Oka K; Nakazawa M; Mukai R; Abe T
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):740-8. PubMed ID: 2533446
[TBL] [Abstract][Full Text] [Related]
18. Aggressive pleomorphic CD2+, CD3-, CD56+ lymphoma with t(5;9)(q31;q34) abnormality.
Wong KF; Chan JK; Ma SK; Lai KY
Cancer Genet Cytogenet; 1995 Jul; 82(1):73-5. PubMed ID: 7543014
[TBL] [Abstract][Full Text] [Related]
19. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
20. CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy.
Kato N; Yasukawa K; Kimura K; Sugawara H; Aoyagi S; Mishina T; Nakata T
J Am Acad Dermatol; 2001 Feb; 44(2):231-8. PubMed ID: 11174380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
